American Funds Global Insight 529-F-3 (CGVHX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
24.68
+0.19 (0.78%)
Feb 13, 2025, 4:00 PM EST
12.95% (1Y)
Fund Assets | 10.72B |
Expense Ratio | 0.52% |
Min. Investment | $250 |
Turnover | n/a |
Dividend (ttm) | 0.29 |
Dividend Yield | 1.16% |
Dividend Growth | -9.57% |
Payout Frequency | Annual |
Ex-Dividend Date | Dec 16, 2024 |
Previous Close | 24.49 |
YTD Return | 5.92% |
1-Year Return | 14.29% |
5-Year Return | n/a |
52-Week Low | n/a |
52-Week High | n/a |
Beta (5Y) | n/a |
Holdings | 205 |
Inception Date | Oct 30, 2020 |
About CGVHX
The American Funds Global Insight 529-F-3 (CGVHX) seeks to provide prudent growth of capital and conservation of principal. CGVHX invests in common stocks of issuers around the world that the adviser believes have the potential for growth, many of which have the potential to pay dividends. It will invest at least 80% of net assets in equity-type securities.
Category World Large-Stock Blend
Performance Rating Average
Risk Rating Below Average
Stock Exchange NASDAQ
Ticker Symbol CGVHX
Share Class Class 529-f-3
Index MSCI World NR USD
Performance
CGVHX had a total return of 14.29% in the past year. Since the fund's inception, the average annual return has been 8.37%, including dividends.
Top 10 Holdings
22.65% of assetsName | Symbol | Weight |
---|---|---|
Capital Group Central Cash Fund | n/a | 4.10% |
Broadcom Inc. | AVGO | 3.73% |
Microsoft Corporation | MSFT | 2.62% |
Apple Inc. | AAPL | 2.49% |
Novo Nordisk A/S | NOVO.B | 1.83% |
AstraZeneca PLC | AZN | 1.71% |
Safran SA | SAF | 1.70% |
JPMorgan Chase & Co. | JPM | 1.53% |
SAP SE | SAP | 1.49% |
Alphabet Inc. | GOOGL | 1.45% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 16, 2024 | $0.2853 | Dec 17, 2024 |
Dec 11, 2023 | $0.3155 | Dec 12, 2023 |
Dec 12, 2022 | $0.259 | Dec 13, 2022 |
Dec 13, 2021 | $0.1781 | Dec 14, 2021 |
Dec 14, 2020 | $0.1568 | Dec 15, 2020 |